ID   HuO9N2
AC   CVCL_2958
SY   HUO9N2; HuO 9N2; O9N2
DR   CLO; CLO_0009876
DR   CLO; CLO_0050809
DR   BioSample; SAMN03470948
DR   GEO; GSM320821
DR   RCB; RCB2532
DR   TKG; TKG 0451
DR   Wikidata; Q54896891
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=2691514;
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in athymic nude mice after two passages.
CC   Doubling time: ~5 days (Note=Lot 031297) (JCRB=JCRB0428).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
ST   Source(s): JCRB=JCRB0428; PubMed=25877200; RCB=RCB2532; TKG=TKG 0451
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 11,13
ST   Penta E: 17,21
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 23
RX   DOI=10.11418/jtca1981.16.3_173;
RA   Mihara K., Miyazaki M., Fushimi K., Tsuji T., Inoue Y., Fukaya K.-i.,
RA   Ohashi R., Namba M.;
RT   "The p53 gene status and other cellular characteristics of human cell
RT   lines maintained in our laboratory.";
RL   Tissue Cult. Res. Commun. 16:173-178(1997).
RX   PubMed=2691514; DOI=10.1007/BF00391353;
RA   Kawai A., Ozaki T., Ikeda S., Oda T., Miyazaki M., Sato J., Taketa K.,
RA   Inoue H.;
RT   "Two distinct cell lines derived from a human osteosarcoma.";
RL   J. Cancer Res. Clin. Oncol. 115:531-536(1989).
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).